NCT03961763View on ClinicalTrials.gov

Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2018

Conditions
Cardiovascular DiseasesHyperlipidemiasDyslipidemias
Interventions
DIETARY_SUPPLEMENT

EPA+DHA

4 g/day EPA+DHA in tablets of 1g, 4 tablets daily, over 8 weeks (56 days)

OTHER

Placebo

4 g/day olive oil placebo in tablets of 1g, 4 tablets daily, over 8 weeks (56 days).

Trial Locations (1)

Unknown

Pax Clinic, Istanbul

All Listed Sponsors
lead

University of Chester

OTHER

NCT03961763 - Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins | Biotech Hunter | Biotech Hunter